EUVIMEDEUVIMED entdecken
Crossref

Preformed Donor-Specific Antibodies in Kidney Transplant: A Center Experience

Sara Vilela, Catarina Eusébio, Pedro Bravo, Carlos Oliveira

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Sara Vilela und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Hospital Garcia de Orta, Almada, Portugal. Electronic address: sararbvilela@gmail.com. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The presence of preformed donor-specific alloantibodies (DSAs) at the time of transplantation has been associated with an increased risk of rejection, dysfunction, and shorter survival. Detection and identification of these antibodies have improved with more sensitive assays, but their clinical relevance and influence on long-term outcomes are unclear. METHODS: We investigate the impact of pretransplant DSAs on the outcomes of kidney transplantation. A retrospective analysis was conducted on all patients who received a deceased donor kidney transplant in our center between January 2017 and December 2021. The study population consisted of 75 kidney transplantations, and DSAs were detected in 15 patients (20%) before transplantation. RESULTS: There was no significant difference in delayed graft function, serum creatinine level at discharge and the first year after transplant, acute rejection rates, or graft survival in patients with and without preformed DSAs. CONCLUSIONS: Detecting pretransplant DSAs by highly sensitive assays may not necessarily impact long-term graft outcomes, and the mismatch should be individually evaluated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansRetrospective StudiesGraft RejectionHLA AntigensTissue DonorsIsoantibodiesGraft SurvivalKidney

Substanzen

HLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Nephrology Department, Hospital Garcia de Orta, Almada, Portugal. Electronic address: sararbvilela@gmail.com.
  • Nephrology Department, Hospital Garcia de Orta, Almada, Portugal.

Zitieren

APA

Vilela, S., Eusébio, C., Bravo, P., & Oliveira, C. (2023). Preformed Donor-Specific Antibodies in Kidney Transplant: A Center Experience. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.06.001

Vancouver

Vilela S, Eusébio C, Bravo P, Oliveira C. Preformed Donor-Specific Antibodies in Kidney Transplant: A Center Experience. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.06.001

BibTeX
@article{Vilela2023,
  author = {Vilela, Sara and Eusébio, Catarina and Bravo, Pedro and Oliveira, Carlos},
  title = {Preformed Donor-Specific Antibodies in Kidney Transplant: A Center Experience},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.06.001}
}
Kostenlos starten →